ArticleJournal of Cancer2019

High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy.

Wenhao Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.